Caged ligands and uses thereof
View Patent ↗Provided are caged compounds comprising a ligand that specifically reacts with a receptor not naturally present in mammals. The cage is released from the ligand upon illumination of the compound with light. Also provided are cells transfected with a gene of interest and a gene encoding a receptor, the gene of interest operably linked to a genetic element capable of being induced by the receptor when bound to a ligand, and the receptor not naturally present in the species of the cell. The cells also comprise a caged ligand of the receptor. Additionally provided are methods of inducing a gene of interest in the above cells. Also provided are methods of repressing a gene of interest in a cell using caged ligands of receptors. Methods are additionally provided for inducing elimination of a target sequence in a cell of a species, using a caged ligand and a recombinase.
1. A compound comprising a ecdysteroid ligand that specifically reacts with an ecdysone receptor and a molecular cage covalently bound to the ecdysteroid ligand that prevents reaction of the ecdysteroid ligand with the ecdysone receptor, wherein the ecdysteroid ligand is released from the cage and capable of reacting with the ecdysone receptor upon exposure of the compound to light and wherein the molecular cage comprises a nitromethoxybenzyl moiety.
2. The compound of claim 1 , wherein the ligand is an inhibitor of the receptor.
3. The compound of claim 1 , wherein the ligand is selected from the group consisting of ecdysone, 20-hydroxyecdysone, ponasterone A, muristerone A, and inokosterone.
4. The compound of claim 1 , wherein the nitromethoxybenzyl moiety is 1-methyl-4,5-dimethoxy-2-nitrobenzene.
5. The compound of claim 4 , wherein the compound is
6. The compound of claim 1 , wherein the molecular cage is a two-photon cage.
7. The compound of claim 1 , wherein the light comprises wavelengths at 300-400 nm.
8. The compound of claim 1 , wherein the light comprises wavelengths at 325-375 nm.
9. The compound of claim 4 , wherein the compound is